VKTX
Closed
Viking Therapeutics Inc
54.13
-1.26 (-2.27%)
Last Update: 06 Sep 2024 23:19:00
Yesterday: 55.39
Day's Range: 51.7 - 55.63
Send
sign up or login to leave a comment!
When Written:
17.69
Viking Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops therapies for metabolic and endocrine disorders. The company's lead product candidate is VK5211, a selective androgen receptor modulator (SARM) for the treatment of muscle wasting and osteoporosis. Viking is also developing VK2809, a thyroid beta agonist for the treatment of lipid disorders and non-alcoholic fatty liver disease (NAFLD), and VK0214, a liver-directed thyroid beta agonist for the treatment of X-linked adrenoleukodystrophy (X-ALD). The company was founded in 2012 and is headquartered in San Diego, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!